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Background: The possible mechanism(s) of inotropic and chronotropic effects of the extract from Rosa damascena
(R. damascena) on heart was examined.
Methods: Inotropic and chronotropic effects of four concentrations of the extract from R. damascena and
isoprenaline were examined in isolated guinea-pig hearts perfused through aorta in a Langendorff model. All
measurements were performed in three different groups: 1) In the presence and absence of propranolol, 2) In the
presence and absence of methacholine and 3) In the presence of diltiazem (n = 12 for each group).
Results: In all groups both isoprenaline and the extract caused an increase in heart rate and contractility (p < 0.05
to p < 0.001). Only in group 1, the final concentration of isoprenaline in the absence of propranolol caused
significant greater increase in heart rate compared to the extract (207.6 ± 11.0 compared to 162.6 ± 11.8, p < 0.01).
The percent increase in heart contractility due to the final concentration of the extract in the absence (362.4 ± 36.9
compared to 227.7 ± 31.6, p < 0.01) and presence of propranolol (577.1 ± 62.9 compared to 357.5 ± 45.6, p < 0.001)
in group 1 and absence (403.7 ± 42.1 compared to 244.8 ± 18.9, p < 0.005) and presence of methcholine
(499.88 ± 64.64 compared to 323.90 ± 44.49, p < 0.05) in groups 2 was significantly greater than the increase caused
by isoprenaline.
Conclusions: The results of this study suggest that inotropic and chornotropic effect of R. damascena is possibly
due to the stimulatory effect of this plant on beta-adrenoceptors.
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Heart failure is a major cardiovascular problem, a syndrome
with various etiologies that results in impaired quality of life
and shortened life expectancy [1]. Positive inotropic drugs
have therapeutic value in heart failure [2] but currently
available classes of cardiotonic drugs limit their clinical
usefulness [3]. Major available inotropic drugs include
sympathetic stimulants, phosphodiesterase (PDE) inhibitors,
digitalis glycosides and calcium channels openers [1].
Heart rate reflects the dynamic balance between
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distribution, and reproduction in any mediumnervous system. Sympathetic stimulators or parasympa-
thetic inhibitory agents are able to increase heat rate.
Chronotropic incompetence (CI) is the inability of heart to
increase its rate commensurate with increased activity or
demand and is common in patients with cardiovascular
disease with particular emphasis on its prominent role in
HF. Therefore positive chrontropic agents could be of
therapeutic values in these patients [4].
R. damascena is cultivated in all over the world
including Iran (especialy in Kashan) for visual beauty and
its scent [5]. Flowers of this plant are large, showy and
colorful. This plant contains carboxylic acid [6], terpene,
myrcene, and vitamin C [7]. Kaemfrol and glycoside are
two other constituents of this plant [8]. The plant also
containe phenolic compound which could be used as
anti-oxidant [8].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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and chest pain, strengthening heart [9], treatment of
menstrual bleeding, digestive problems [10], and anti
inflammation has been described for R. damascena. A
decoction of the root of R. damascena as a cough
remedy to ease children’s cough [5] and the plant as a
gentle laxative are also used [11]. The anti HIV [12],
hypnotic [13,14], antispasmodic [15], anti-inflammatory,
analgesic [16], antioxidant, hepatoprotective, antidiabetic
[17,18] and antidepressant [19] effects for this plant were
also reported. The antitussive [20] and relaxant effect of
R. damascena [21] and its fractions [22] on guinea pig
trachea were also demonstrated. In a recent review article,
different pharmacological effect of R. damascena was
summerized [23]. Cardiotonic effect was previously
described for R. damascena [24]. In a recent study, the
effect of the plant on heart rate and contractility was
demonstrated [25].
In the present study, the possible mechanism(s) of
ionotropic and chronotropic effects of the aqueous-
ethanolic extract from R. damascena was examined.
Methods
Plant and extracts
R. damascena was the same plant used in our previous
study [25]. A voucher specimen was preserved in the
Herbarium of the school of Pharmacy, Mashhad University
of Medical Sciences (Herbarium No: 254-1804-01). The
Aqueous-ethanolic extract was prepared as previously
described for R. damascena and other plants [21,25,26].
The plant ingredient concentration in the final extract
was 10 g%.
Preparation of the isolated hearts
Dunkin Hartley guinea pigs of either sex, with a body
weight of 400 - 500 g, were used in the present study
(Razi Institute, Mashhad, Iran). Preparation of isolated
heart was carried out exactly as previously described
[25,27,28]. The hearts were perfused with K-H buffer solu-
tion (37°C, pH 7.4, saturated with 95% O2 and 5% CO2)
through aorta on a modified Langendorff apparatus at
a constant perfusion pressure of 70 mmHg [25]. The
K-H buffer solution contained the following ingredients
(in mMol/L): NaCl 118, NaHCO3 25.0, KCl 4.7,
KH2PO4 1.2, MgSO4 1.2, CaCl2 2.5, and glucose 11.0
(Merck, Germany) and equilibrated with 95% O2 + 5%
CO2 at 37°C. All the hearts were first perfused with K-H
solution for 20-30 min for stabilization in a Langendorff
apparatus and then the effects of extract from R. damascena
and also isoprenaline were studied.
Protocol of experiments
Heart rate and heart contractility were measured in the
presence of four different concentrations of aqueous-ethanolic extract from R. damascena (0.1, 0.2, 0.4 and
1.0 mg% from the extract), isoprenaline sulphate
(Sigma Chemical Co. Ltd UK), (1, 10 nM, 0.1 and 1 μM)
and compared to baseline values. Each concentration of the
solutions was given as one-minute intracoronary infusion
and its inotropic and chornotropic effects were recorded in
last 30 sec, similar to previous studies [25,27]. For infusion
of each concentration of the extract or isoprenaline, Krebs
solution containing that concentration was infused instead
of Krebs solution alone. Both heart rate and contractility in
the absence of pharmacological intervention were reprodu-
cible which were served as its own control [25,27]. The
effects of different solutions were tested with three different
experimental designs (n = 12 for each group) as follows:
In the presence and absence of 1 μM propranolol
hydrochloride (Sigma Chemical Co. Ltd UK) (group 1),
in the presence and absence of 1 μM methacholine
hydrochloride (Sigma Chemical Co. Ltd UK) (group 2),
and in the presence of 10 μM diltiazem (group 3).
Three different series of animal hearts were used for
examination of three groups of experiments. In each
heart, the effects of the aqueous-ethanolic extract and
isoprenaline were evaluated randomly with a 30-min
resting period while the heart is perfused with Krebs
solution. The heart rate (HR) and contractility were
recorded on a kymograph (ET8 G-Boulitt, Paris) and
measured after fixation similar to previous studies
[25,27]. The local Animal Research Committee of Mashhad
University of Medical Sciences approved the experimental
procedures used in the present study. Animal care
procedures were performed in accordance with the
National Institutes of Health Guide for Care and Use
of Laboratory Animals.
Statistical analysis
The data were expressed as mean ± SEM. The data of
each concentration of the extract in each group were
compared with those of isoprenaline using paired "t" test.
The percent increase in heart rate and contractility due
to final concentration of the extract and isoprenaline in
each group were also compared using paired "t" test.
The data obtained in the presence of different concen-
trations and baselines were compared using ANOVA
test in each group. The effect of the aqueous extract and
isoprenaline were related to the concentrations of the
solutions using least square regression. Significance was
accepted at p < 0.05.
Results
The effect of the extract and isoprenaline on heart rate
In experimental group 1, both isoprenaline and the extract
caused concentration dependent and significant increase
in heart rate (p < 0.001 for all cases). In addition, all
concentrations of isoprenaline and the extract significantly
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for all concentrations), (Figure 1). In experimental group 2,
also isoprenaline and the extract caused concentra-
tion dependent increase in heart rate (p < 0.001 for all
concentrations). All concentrations of isoprenaline and theFigure 1 Concentration response curves of aqueous-ethanolic extract
pigs in group 1 (in the presence and absence of propranolol), (a for t
(in the presence and absence of methacholine), (c for the isoprenalin
(e for the extract). Statistical differences between the data in the presenc
Statistical differences between the data of each concentration of extract or is
p < 0.001. (n = 12 for each group).extract significantly reversed the effect of methacholine on
heart rate (p < 0.001 for all concentrations), (Figure 1). In
experimental group 3, all concentrations of the extract
significantly reversed the effect of diltiazem on heart
rate (p < 0.001 for all concentrations), (Figure 1). In groupfrom R. damascena and isoprenaline, on heart rate of guinea
he isoprenaline and b for the extract), group 2 experiments
e and d for the extract) and group 3 (in the presence diltiazem),
e and absence of propranolol and methacholie; *; p < 0.05, **; p < 0.01.
oprenaline compared to baseline value; +; p < 0.05, ++; p < 0.01, +++;
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tration of isoprenaline (1 μM) in the absence of propranolol
was significantly greater than that of the extract (p < 0.01),
(Table 1). In group 2, there was no significant difference
between the percent increase in heart rate caused by
the final concentration of isoprenaline and extract both
in absence and presence of methacholine (Table 1).
The effect of the extract and isoprenaline on heart
contractility
In experimental group 1, both isoprenaline and the
extract caused concentration dependent and significant
increase in heart contractility (p < 0.05 to p < 0.001). All
concentrations of isoprenaline and the extract significantly
reversed the effect of propranolol on heart contractility
(p < 0.05 to p < 0.001), (Figure 2). In experimental group 2
also isoprenaline and the extract caused concentration
dependent increase in heart contractility (p < 0.05 to
p < 0.001). All concentrations of isoprenaline and the
extract significantly reversed the effect of methacholine
on heart contractility (p < 0.005 to p < 0.001), (Figure 2).
In experimental group 3, all concentrations of the extract
significantly reversed the effect of diltiazem on heart
contractility (p < 0.05 to p < 0.001), (Figure 2). The percent
increase in heart contractility due to the final concentration
of the extract (1.0 mg%) in the absence and presence
of propranolol was significantly greater than that of
isoprenaline (p < 0.01 for both cases) in group 1 (Table 1).
The percent increase in heart contractility due to the final
concentration of the extract in the absence and presence
of methacholine was also significantly greater than that of
isoprenaline (p < 0.05 and p < 0.001 for the absence and
presence of methacholine), (Table 1).
Differences in the heart rate and contractility before and
after propranolol, methacoline and diltiazem
Propranolol, methacholine and diltiazem caused significant
reduction in heart rate (p < 0.05 for propranolol and
methacholine and p < 0.005 for diltiazem) and its contractil-
ity (p < 0.05 for all cases). However, the increase in heart
rate and contractility due to the final concentration of
isopranaline and the extract in the presence of propranolol
and methacholine was greater than the increase in absenceTable 1 Increased heart rate and contractility due to the fina
(precent propertion to baseline values in group 1 and 2 expe
extract and isoprenaline)
Experimental design Isoprenaline Extract
Group 1 Rate 207.6 ± 11.0 162.6 ± 11.8
Contractility 227.7 ± 31.6 362.4 ± 36.9
Group 2 Rate 192.8 ± 12.9 204.2 ± 10.2
Contractility 244.8 ± 18.9 403.7 ± 42.1
Data were expressed as mean ± SEM. An.: antagonist. St.Di: Statistical difference.of them in most cases which were significant in some cases
(p < 0.01 for heart rate due to the extract after propranolol,
p < 0.05 for heart rate due to isoprenaline and the extract
after methacholine and p < 0.05 for heart contractility due
to the extract after methacholine), (Figures 1 and 2).
Relationship between concentration and the effect of the
aqueous-ethanolic extract and diltiazem
Significant correlations were seen between both heart rate
and heart contractility and concentration of isoprenaline
and the extract in all three groups of experiments
(P < 0.01 to p < 0.001), (Table 2).
Discussion
Concentration dependent increase in both heart rate and
heart contractility due to the aqueous-ethanolic extract
of R. damascena was observed in the present study with
prominent effect of the extract on heart contractility
(ionotropic effect).
The effect of the extract was also examined on pre-
treated heart with propranolol, methacholine and diltiazem
to explore the possible mechanism(s) for inotropic and
chornotropic effects of the plant. The effect of propranolol
on both heart rate and contractility was significantly and in
a dose dependent manner reversed by the extract which
was more prominent on heart contractility. In fact,
propranolol led to a significant reduction in heat rate
and contractility. Even low concentration of isoprenalie
and the extract caused less increase in heat rate and
contractility in presence of propranolol compared to
its absence. However, inceasing the concentration of
isoprenaline and the extract overcome the effect of
propranolol simillary which is a well known characteristic
of competitive antagonist and agonist interaction. In
pre-treated heart with propranolol, the effect of the
extract on heart rate was lower but its effect on contractil-
ity was greater than that of isoprenaline. In experimental
group 2, the extract, significantly and in a dose dependent
manner, reversed the effect of methacholine on both heart
rate and contractility with a greater effect on heart con-
tractility rather than heart rate. The effect of the extract
on contractility of pre-treated heart with methacoline was
also greater than that of isoprenaline. In experimentall concentration pof the extract and isoprenaline
riments and the statistical differences between the
St.Dif Isoprenaline + An. Extract + An. St.Dif
p < 0.01 281.8 ± 21.9 248.6 ± 21.0 NS
p < 0.01 357.5 ± 45.6 577.1 ± 62.9 p < 0.01
NS 308.7 ± 31.0 303.4 ± 36.6 NS
p < 0.005 323.9 ± 44.5 499.9 ± 64.6 p < 0.05
Figure 2 Concentration response curves of aqueous-ethanolic extract from R. damascena and isoprenaline, on heart contractility of
guinea pigs in group 1 (in the presence and absence of propranolol), (a for the isoprenaline and b for the extract), group 2 experiments
(in the presence and absence of methacholine), (c for the isoprenaline and d for the extract) and group 3 (in the presence diltiazem),
(e for the extract). Statistical differences between the the data in the presence and absence of propranolol and methacholie; NS: non-significant
difference, *; p < 0.05, **; p < 0.01. Statistical differences between the data of each concentration of extract or isoprenaline compared to baseline
value; +; p < 0.05, ++; p < 0.01, +++; p < 0.001. (n = 12 for each group).
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dependent manner, reversed the effect of diltiazem on both
heart rate and contractility. In this group the effect of the
extract on contractility of pre-treated heart with diltiazem
was also greater than the effect on heart rate.The results of the present study increased heart rate
and contractility as well as significant correlation
between concentrations of the extract and its effects on
heart rate and heart contractility and its similar effect to
isoprenaline support the choronotropic and inotropic effect
Table 2 Correlation between the effects of aqueous-ethanolic extract from R. damascene and isoprenaline on heart
rate and contractility of isolated guinea pig heart with concentrations in three groups of experiments
Groups Extract Extract + An.: antagonist. Isoprenaline Isoprenaline + An.: antagonist
R P value R P value r P value r p value
Group 1 HR 0.4 p < 0.005 0.6 p < 0.001 0.7 p < 0.001 0.7 p < 0.001
Cont 0.4 p < 0.01 0.6 p < 0.001 0.3 p < 0.05 0.7 p < 0.001
Group 2 HR 0.6 p < 0.001 0.6 p < 0.001 0.7 p < 0.001 0.7 p < 0.001
Cont 0.7 p < 0.001 0.7 p < 0.001 0.3 p < 0.05 0.6 p < 0.001
Group 3 HR 0.5 p < 0.001
Cont 0.5 p < 0.001
For abbreviations see Table 1.
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previous study [25]. The results also showed that the
extract reversed the effects of pre-treated heart with
propranolol, methacholine and diltiazem. These findings
suggest that the possible mechanisms of action of the
extract from R. damascena on heart are β-adrenoceptor
stimulatory, calcium channel opening activity or inhibitory
effect on cholinergic receptors [29]. The findings on pre-
treated heart with propranolol were also supported by our
previous study [25]. However, if the hydro-ethanolic extract
has a blockade effect on cholinergic receptors, it should
increase heart rate more than contractility. The results of
the present study showed that the extract affects heart
contractility more than heart rate. Therefore the inhibitory
effect of the extract on cholinergic receptors of the heart is
excluded. Although the extract reversed the effect of diltia-
zem on both heart rate and contractility which may indicate
an opening effect of the extract on calcium channels. With
regard to the greater effect of calcium channel opener drugs
on heart contractility than heart rate which is similar to the
results of the present study, the extract of R. damascena
may have an opening effect on calcium channels of heart.
However, the most possible mechanism of action of
hydro-ethanolic extract on heart is suggested to be the
stimulatory effect on β-adrenoceptor because the extract
increased both heart rate and contractility. In addition, if
the extract has a stimulatory effect on β-adrenoceptors,
it can reverse the effect of both methacholine and diltiazem
in a functional antagonism manner. However, the inhibitory
effect of the extract on cholinergic receptors and its
opening effect on calcium channels could not be fully
excluded because the hydro-ethanolic extract is composed
of several constituents and could have several mechanisms
of action. In fact a muscarinic receptor inhibitory effect for
R. damascena was shown in a recent study [15]. Therefore,
the inhibitory effect of the plant on muscarinic receptors
and its opening effect on calcium channels should be inves-
tigated in more detailed studies. In addition, the effect of
different fractions of the extract also needs to be studied on
heart activities and the mechanism(s) of their actions
should be explored in further studies.The other possible mechanism of action of the plant is
an increased cAMP level like phosphodiestrase III inhib-
ition [30] or forskolin-like action [31] of R. damascena.
These possible mechanisms of action of the plant also
should be examined in further studies. Because of the
solution used for heart perfusion, contained ca2+ ion it
is possible that the extract or drug could interact with
calcium ion and calcium chelating is formed. However if
such interactions had happened, the decrease in heart
rate and specially contractility should have been observed.
The results showed heart rate and contractility increasing
effects for isoprenaline and the extract which suggest the
abscence of interactions between the extract or drug and
calcium ion.
Choronotropic and inotropic effect of the extract of R.
damascenaobserved in the present study with a possible
stimulatory effect on β-adrenoceptors may represent a
pharmacological action and a therapeutic value in various
cases of cardiac impairment such as lack of activator of
calcium (e.g: hypocalcemia), [32,33].
Conclusions
In conclusion, this study supports a potent inotropic and
chornotropic effect for R. damascena on isolated guinea pig
heart with possible stimulatory effect on β-adrenoceptor of
isolated guinea pig heart. In addition the results may also
suggest an opening effect on calcium channels and/or an
inhibitory property for the plant on muscarinic reptors of
isolated heart.
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